M&A Deal Summary

CoorsTek Medical Acquires Innovative Medical Device Solutions

On September 13, 2013, CoorsTek Medical acquired medical products company Innovative Medical Device Solutions from Arsenal Capital Partners

Acquisition Highlights
  • This is CoorsTek Medical’s 1st transaction in the Medical Products sector.
  • This is CoorsTek Medical’s 1st transaction in the United States.
  • This is CoorsTek Medical’s 1st transaction in Texas.

M&A Deal Summary

Date 2013-09-13
Target Innovative Medical Device Solutions
Sector Medical Products
Buyer(s) CoorsTek Medical
Sellers(s) Arsenal Capital Partners
Deal Type Add-on Acquisition

Target

Innovative Medical Device Solutions

Fort Worth, Texas, United States
Innovative Medical Device Solutions is the strategic source for the contract, full-service medical device development, and manufacturing. The company delivers products that enhance the quality of life and standard of care for patients. Innovative Medical Device Solutions is based in Fort Worth, Texas.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CoorsTek Medical

Fort Worth, Texas, United States

Category Company
Sector Medical Products
DESCRIPTION

CoorsTek Medical LLC offers casting and machining of a wide variety of implants and instruments combined with a full range of product development services which allow the company to provide a true “Concept to Launch” service to its OEM customers.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2013 M&A 1 of 1

Seller(S) 1

SELLER

Arsenal Capital Partners

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2000
PE ASSETS 10.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Arsenal Capital Partners is a private equity firm focused on middle-market healthcare, specialty industrial, and financial service companies. Specifically, Arsenal looks to acquire businesses in the areas of specialty chemicals, aerospace/defense, transportation, environmental services, business services, insurance, asset management, financial technology, medical products, healthcare IT, and healthcare contract research/manufacturing. The Firm typically seeks to commit $50 to $300 million per investment in profitable businesses with at least $10 million of EBITDA. Funds are generally used to support buyouts, recapitalizations, growth financings, consolidations, and divestitures. The Firm avoids investing in companies reliant on high levels of technology. Arsenal Capital Partners was formed in 2000 and is headquartered in New York City.


DEAL STATS #
Overall 12 of 36
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 7 of 17
State: Texas M&A 2 of 6
Country: United States M&A 12 of 33
Year: 2013 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-28 Solvaira Specialty

North Tonawanda, New York, United States

Solvaira Specialty LP is a producer of powdered cellulose and fiber filler products used for food and industrial applications. Solvaira Specialty was founded in 1917 and is based in North Tonawanda, New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-09 Flowchem

Waller, Texas, United States

Flowchem is a global provider of drag-reducing agents, related support services and equipment to midstream crude oil and refined fuel pipeline operators. Drag reducing agents, also known as DRAs, are specialty chemicals injected into midstream pipelines to reduce friction near the pipeline walls and within the turbulent fluid flowing through the pipeline network. Flowchem was founded in 2001 and is based in Waller, Texas.

Buy -